Combination effect of ultrasound-guided superior cervical ganglion block and standard triptan for migraine attacks
Abstract
BACKGROUND: To examine whether the combination of ultrasound (US)-guided superior cervical ganglion (SCG) block with standard triptans has a superior relief of headache as compared to triptans alone for acute migraine.
METHODS: The retrospective-prospective cohort study enrolled patients presenting with acute migraine. The records of 243 cases receiving standard triptans and an adjunctive US-guided SCG were reviewed, while 230 cases were prospectively enrolled to receive triptan alone for control after age and sex matching in a 1:1.2 ratio. The primary endpoint was sustained headache relief and complete freedom from pain within post-procedural 24 hours. Secondary outcomes included headache relief and freedom from pain at 2 hours, monthly migraine days (MMDs), migraine disability assessment (MIDAS) scores, migraine-specific quality of life questionnaire (MSQ) scores, need for rescue analgesics use and adverse events.
RESULTS: Sustained headache relief was observed in 69.5% of cases in the SCG cohort, yielding a superior outcome increased by 21.7% (95% confidence interval (CI): 13.1%, 30.4%) (p < 0.001). Overall, SCG block plus triptans had a better effect on headache relief and freedom from pain at post-procedural 2 hours, and sustained freedom from headache within 24 hours compared to triptans alone. At 1-month visit, SCG cohort also showed a greater improvement in MMDs (p < 0.01), MIDAS scores (p = 0.040) and MSQ scores (p = 0.036). No major adverse events were observed.…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.